Kiran Mazumdar Shaw

Kiran Mazumdar Shaw

• 1.
  Kiran Mazumdar Shaw Presented by: PrernaNambiar Ramki Thivya Muthu Muthu Tharun Svarna
• 2.
  Life… Schooling at BishopCotton Girls School & Mount Carmel College at Bangalore Born on 23rd March, 1953 in Bangalore B.Sc in Zoology from Bangalore University Qualified as a master brewer from Ballarat Universtiy, Australia CMD, Biocon Ltd., India’s biggest Biotechnology Company In 2004, she became India’s Richest Woman
• 3.
  Personal Life… John Shawheaded a leading textiles MNC, Madura Coats from 1991 to 1998 as CMD. Kiran Mazumdar Shaw is married to John Shaw, a Scotsman and Indophile. Currently, John Shaw is Vice-Chairman of Biocon, Ltd. She has huge collections of paintings and other art works. She has also written a coffee table book named “Ale & Arty”- the story of Beer.
• 4.
  Philanthropic activities In 2004,Kiran started the Biocon Foundation to conduct health, education, sanitation, and environmental programs to benefit of the economically weaker sections of society. All the clinics maintained by Biocon organize regular general health checks in remote villages by bringing in physicians and doctors from network hospitals. Each year, the Foundation touches more than 300,000 lives through its holistic healthcare approach. She helped establish a 1,400-bed cancer care center at the Narayana Health City campus at Boommasandra in 2007.
• 5.
  Personal Recognition… NATIONAL INSTITUTEOF MARKETING MANAGEMENT, INDIA ROTARY CLUB, KARNATAKA PADMASHRI, GOI INTERNATIONAL WOMENS ASSOCIATION, CHENNAI ERNST & YOUNG HIGHEST CIVILIAN HONOURS EXPRESS PHARMACEUTICAL LEADERSHIP SUMMIT AWARD FORBES LIST 1982 1983 1989 1999 2002 2005 2009 2010
• 6.
  BIOCON India’s Leading Biotechenterprise •Established in 1978 •Focus on development of Bio-pharmaceuticals •1stin Asia & 16th in world in terms of revenue and market capitalization •Syngene, India’s first bio-tech custom research company in drug discovery •First company to manufacture human insulin Using a Pichia expression system •India’s first billion dollar bio-tech company Biocon's key innovations include insulin analogue Glargine, BASALOG® and India's first indigenously produced monoclonal antibody BioMAb-EGFR® , for head & neck cancer. INSU Pen® is a next generation affordable insulin delivery device introduced in India by Biocon.
• 7.
  Journey of BioconUnder her wings.. In 1978 itself, she started Biocon in he garage in Bangalore with a capital of Rs. 10,000. In 1978, she joined Biocon Biochemicals Limited, of Cork, Ireland as a Trainee Manager. Within a year, Biocon became the first Indian company to manufacture and export enzymes to USA and Europe. In 1990, she upgraded Biocon’s in-house research program, based on a proprietary solid substrate fermentation technology. The commercial success of this program led to a three-fold expansion by 1996 and Biocon entered the biopharmaceuticals and statins segments In 1998, when Unilever agreed to sell its shareholding in Biocon to the Indian promoters, Biocon became an independent entity. Within a year, Biocon became the first Indian company to manufacture and export enzymes to USA and Europe. In 1990, she upgraded Biocon’s in-house research program, based on a proprietary solid substrate fermentation technology.
• 8.
  By 2003 Bioconbecame the first company worldwide to develop human insulin on a Pichia expression system. In 2000, Biocon's proprietary bioreactor, christened PlafractorTM, based on solid matrix fermentation received a U.S. patent. In 2004, she decided to access the capital markets to develop Biocon’s pipeline of research programs. Biocon’s IPO was oversubscribed 32 times and its first day at the bourses closed with a market value of $1.11 billion. It made Biocon the 2nd only company to cross $1 billion mark on the first day of listing. She entered into more than 2,200 high-value R&D licensing and other deals within the pharmaceuticals and bio-pharmaceutical space between 2005 & 2010
• 9.
  Biocon’s state ofthe art Human Insulin Facility
• 10.
  Business in BIOCON SplitBusiness Technique(SBT) Divided business: Syngene - company dealing in laboratory setups and micro-biological reasearch Clinigene – clinical research organisation Biocon – biotechnology products All these companies are owned by Kiran M. Shaw which makes her the richest lady in India.
• 11.
  Departments of Biocon TopManagement Middle level Management HRM FINANCE MARKETTING OPERATIONS IT QA & QC PACKAGING REGULATORY AFFAIRS
• 12.
  HRM in Biocon †Biocon employees approximately 3600 qualified personnel. † 15% of Biocon are women † The average age of employees is 29 years.
• 13.
  Products Of Biocon Anti-DiabeticAgents Anti-Hypertensive Agents Anti-Inflammatory Agents Antioxidants Cardiovascular Agens Digestive Aid Enzymes Haemostatic Agents Hepatoprotective Agents Immunosuppressants Nutraceuticals
• 14.
  Financial Front The paidup capital of Syngene as on March 31st, 2009 is Rs.28,750,000. The paid up capital of Clinigene as on March 31st, 2009 is Rs.500,000. The subscribed capital on 31st, 2008 of Axicorp is 7,950,000. The paid up capital of BBPL as on March 31st 2009 is Rs. 176,000,000. The paid up capital of NeoBiocon as on March 31st 2009 is 45,250,000. SHARE PRICE – 228.95 (BSE)
• 15.
  Biocon’s Achievement… Med AdNews, in its 2007/08 listings has ranked Biocon 20th amongst the leading biotechnology companies in the world. Med Ad News, in its 2007/08 listings also ranked Biocon as 7th Largest Employer in the world. Biocon also recently received the 2009 Bio Singapore Asia Pacific Biotechnology Award for Best Listed Company